NEWS

INTCO Medical, the world’s largest latex-free nitrile gloves manufacturer, achieved two significant distinctions at the Times Finance Golden Orange Awards during the “Influence · Times Sustainable Development Innovation Annual Conference” held in Chengdu on November 20. The company received the 2025 High-Quality Development Listed Company Award, while Board Secretary Ms. Feng Jie was honored with the 2025 Innovative Gold Medal Board Secretary Award. These recognitions affirm INTCO Medical’s excellence in sustainable growth, corporate governance, and global competitiveness.

Excellence Recognized by a Highly Respected Evaluation System

The Times Finance Golden Orange Awards are renowned for their rigorous, objective, and authoritative assessment standards, honoring enterprises and individuals that demonstrate exceptional performance across economic value, governance, innovation, and social contribution. INTCO Medical’s recognition reflects its solid foundation in medical consumables, rehabilitation products, and diversified global operations. This strength is rooted in its comprehensive development strategy and long-term vision embedded within its evolving corporate identity.

Advancing High-Quality Development in a Complex Global Landscape

Throughout the past year, INTCO Medical upheld its core strategy of high-quality development despite global challenges. The company continued expanding its leadership in the global disposable glove market, particularly through its portfolio of latex-free nitrile gloves, vinyl gloves, and PE gloves—key product lines within its comprehensive medical portfolio.

Breakthroughs in R&D, intelligent manufacturing, and international production capacity further strengthened INTCO’s competitive edge. Continuous optimization in product mix, operational efficiency, and ESG performance accelerated steady progress. 

Outstanding Corporate Governance Recognized Through National-Level Honor

The distinction awarded to Ms. Feng Jie as the recipient of the 2025 Innovative Gold Medal Board Secretary Award highlights her leadership in capital market communication, investor relations, and corporate governance development. Under her guidance, INTCO Medical has consistently ensured transparency, timeliness, and accuracy in information disclosure.

The company earned the Class A (Excellent) rating in the 2024 annual disclosure assessment—representing the highest level of recognition issued by regulatory authorities. This accomplishment demonstrates INTCO Medical’s dedication to responsible governance, reflected in its evolving investment framework.

Dual Honors Mark a Milestone and a New Beginning

Receiving two major awards at the Times Finance Golden Orange Awards represents a milestone for INTCO Medical. The honors acknowledge its accomplishments in 2024 and provide powerful momentum for its future development. INTCO Medical continues advancing innovation-driven growth, strengthening its manufacturing foundation, and elevating its competitiveness across global healthcare markets. These strategies are embedded within the company’s international footprint and aligned with its broader strategic direction.

Deepening Global Operations and Enhancing Customer Value

Looking forward, INTCO Medical will continue expanding its global industrial layout, advancing digital intelligence in manufacturing, and improving international supply chain resilience. These initiatives support customers, distributors, and partners across global markets.

Continuous improvements in sustainable manufacturing, quality standards, and operational efficiency align with INTCO’s future-oriented environmental commitments. Enhanced customer support and communication channels further strengthen service quality through the company’s integrated global communication networks.

Empowering Future Development with Innovation and Responsibility

The dual honors achieved at the Golden Orange Awards symbolize not only recognition of past success but also renewed motivation for future advancement. INTCO Medical will continue driving innovation, strengthening governance, empowering global healthcare, and promoting sustainable development across its operations.